As shown in bladder cancer cells, decorin binds with similar affinities both the IGF1R and IGF1 at distinct sites and inhibits IGF1-mediated IGF1R phosphorylation, without affecting IGF1R protein levels [151]. The gene discussed is DCN; the disease is urinary bladder carcinoma.